We are live on ! Find out more
WST icon

West Pharmaceutical
WST

309 hedge funds and large institutions have $6.36B invested in West Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 140 increasing their positions, 90 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $577K

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

56% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 90

17% more capital invested

Capital invested by funds: $5.45B → $6.36B (+$918M)

5% more funds holding

Funds holding: 294 → 309 (+15)

0.56% more ownership

Funds ownership: 90.99% → 91.55% (+0.56%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
309
Holders Change
+15
Holders Change %
+5.1%
% of All Funds
7.7%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
140
Reduced
90
Closed
25
Calls
$1.37M
Puts
$577K
Net Calls
+$793K
Net Calls Change
+$673K

Top Buyers

1
RP
Riverbridge Partners
Minnesota
+$47M
2
BlackRock
BlackRock
New York
+$38M
3
Renaissance Technologies
Renaissance Technologies
New York
+$28.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
5
Prudential Financial
Prudential Financial
New Jersey
+$22.1M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$34.7M
2
Millennium Management
Millennium Management
New York
-$29.1M
3
CRCP
Copper Rock Capital Partners
Massachusetts
-$28.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$25.7M
5
EAM
Eagle Asset Management
Florida
-$21.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
LIA
201
LS Investment Advisors
Michigan
$585K +$90.4K +983 +19%
PNC Financial Services Group
202
PNC Financial Services Group
Pennsylvania
$577K -$65.7K -714 -10%
US Bancorp
203
US Bancorp
Minnesota
$569K +$228K +2,475 +70%
SM
204
Sciencast Management
New Jersey
$566K +$271K +2,945 +97%
Teacher Retirement System of Texas
205
Teacher Retirement System of Texas
Texas
$555K +$3.68K +40 +0.7%
QT
206
Quantbot Technologies
New York
$551K -$266K -2,893 -33%
N
207
Natixis
France
$534K +$117K +1,272 +29%
WA
208
Wheatland Advisors
Pennsylvania
$529K – – –
EP
209
Elkfork Partners
Oregon
$526K +$200K +2,178 +64%
SCM
210
Shelton Capital Management
Colorado
$523K – – –
OI
211
Oakbrook Investments
Illinois
$515K +$192K +2,090 +62%
WAM
212
World Asset Management
Michigan
$507K +$19.4K +211 +4%
CANY
213
Caxton Associates (New York)
New York
$473K -$55.2K -600 -11%
Squarepoint
214
Squarepoint
New York
$472K +$221K +2,405 +93%
AWE
215
Avidian Wealth Enterprises
Texas
$467K +$454K +4,937 New
CI
216
Cigna Investments
Connecticut
$458K +$180K +1,961 +68%
HNB
217
Huntington National Bank
Ohio
$445K -$8.28K -90 -2%
TI
218
Trexquant Investment
Connecticut
$425K -$777K -8,447 -65%
KI
219
Koch Industries
Kansas
$409K +$145K +1,572 +57%
CSS
220
Cubist Systematic Strategies
Connecticut
$395K +$161K +1,755 +73%
RFC
221
Regions Financial Corp
Alabama
$386K +$12K +131 +3%
TAM
222
Tyers Asset Management
Texas
$383K +$146K +1,584 +64%
TRIM
223
Thompson Rubinstein Investment Management
Oregon
$378K – – –
WSC
224
Wellington Shields & Co
New York
$378K – – –
BF
225
BOK Financial
Oklahoma
$361K -$92.3K -1,004 -21%
7 8
9
10 11

WST Hedge Fund Activity: Q2 2017 in Review

309 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2017, worth a combined $6.36B — up 17% from $5.45B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new WST positions and 25 closed out — a net gain of 19 holders — while 140 added to existing stakes and 90 trimmed.

The largest buyer was Riverbridge Partners, opening a new position worth an estimated $47M. The largest seller was Victory Capital Management, cutting an estimated $34.7M.

  • 309 institutional investors held West Pharmaceutical (WST) as of Q2 2017, up from 294 in Q1 2017.
  • Funds reported $6.36B of West Pharmaceutical stock for Q2 2017, up 17% quarter-over-quarter.
  • 44 funds opened new West Pharmaceutical positions in Q2 2017 and 25 closed out, a net change of +19 holders.
  • The largest West Pharmaceutical buyer in Q2 2017 was Riverbridge Partners, an estimated $47M added.
  • The largest West Pharmaceutical seller in Q2 2017 was Victory Capital Management, an estimated $34.7M sold.

Based on aggregated 13F filings for Q2 2017.